American Healthcare Capital is proud to introduce a digital pharmacy with unique, end-to-end pharmacy solutions for payers, manufacturers, providers, and patients. This company has truly modernized the pharmacy experience and will disrupt the current pharmacy industry as we know it today. They have full accreditation from URAC Specialty, URAC Mail, National Assoc. of Board Pharmacy Digital Pharmacy, and Joint Commission.
The company has about 100 employees and they are licensed in all 50 states. With its current technology, the pharmacy can reach 90% of the total US Population via mail order. Updates are in beta testing to allow for 98% total US coverage later in 2021.
The company has been phenomenally successful in developing their leading-edge, proprietary technology. This proprietary technology encompasses a complete pharmacy management system, which includes full customization of the prescription journey, API connectivity, and commercial licensing to 3rd parties. Moreover, this technology allows for patient, provider and pharmaceutical portals, real time insights, data analytics, and native mobile applications, in addition to a Telemedicine platform.
Since inception, they have shipped over 2 million scripts, with current daily volume of about 2,000 scripts and the capacity to ship 10,000 scripts per day. Gross revenues are on track to exceed $160 million in 2021. With COVID restrictions lifting and numerous growth opportunities, they expect to be in the $200 million range in 2022. Furthermore, the company is launching a new proprietary pharmacy management platform in 2021 that is projected to generate more than $2 billion in additional revenue by the end of 2024.
The seller will consider all reasonable offers.
If you would like to learn more, please contact us for a Confidentiality Agreement that will allow us to share more detailed information with you.